Life Sciences

FDA finalizes guidance on distribution of reprints

Pharma Compliance Alert, January 14, 2009

Pharmaceutical and medical device manufacturers will find it easier to distribute journal articles detailing off-label and investigational uses of their products since the FDA issued its final guidance on. Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices U.S.

Post a Comment





Please enter your comment below:


Please enter the text below:


Most Popular